Overview
Psyomics is a pioneering digital healthcare company dedicated to transforming mental health care through innovative precision tools. The company's primary platform, Censeo, acts as a digital front door to mental health services, streamlining the process of mental health assessments and triage. Through scalable AI-driven solutions, Psyomics tackles common challenges in mental health such as long waiting lists, service inefficiencies, and reactive, overburdened systems, ultimately optimizing patient engagement and assessment outcomes.
Key Offerings
Censeo: As a comprehensive digital patient interview tool, Censeo is supported by clinical psychologists and psychiatrists from the University of Cambridge. It covers assessments across 15 common mental health conditions, providing clinicians with crucial patient-reported information and assisting healthcare providers with consistent, insightful data for triage and treatment decisions.
- Efficiency and Engagement: Censeo has generated over 6,000 mental health reports and has reduced the number of uncontactable service users by 50% over six months in participating organizations.
- Impact on Healthcare Providers: Healthcare leaders have noted Censeo's significant role in enhancing clinical decision-making, managing waiting lists effectively, and diminishing the administrative burdens on mental health services.
- Client Feedback: Notable clients, including Staffordshire and Hertfordshire NHS Foundation Trusts, report increased productivity and heightened care efficiency following the integration of Censeo.
Recent Developments
- Funding: Psyomics secured £4 million in funding led by Parkwalk Advisors to continue the development and acceleration of its AI-informed medical device, Censeo.
- Awards and Recognition: The company's innovation in mental health technology has resulted in a nomination for the 2024 HSJ Award.
Leadership
CEO Dr. Melinda Rees, an experienced consultant clinical psychologist, spearheads Psyomics. Dr. Rees transitioned from a senior clinical role within the NHS to propel strategic growth and innovation at Psyomics. The leadership team includes prominent figures such as Professor Sabine Bahn, Co-founder and Chief Medical Officer, and Luke Mawbey, Chief Technology Officer.
Academic Collaborations and Research
Psyomics maintains strong academic ties, notably with the University of Cambridge. It has contributed to several high-impact publications in esteemed journals like JAMA Psychiatry and Translational Psychiatry, focusing on distinct diagnostic methodologies and metabolomic biomarker research for mood disorders.
Strategic Vision
The mission of Psyomics is to revolutionize mental health care by facilitating timely access to treatments and enhancing the precision of mental health care pathways. Through technology and academic partnerships, Psyomics is poised to deliver impactful solutions, addressing the global demand for efficient mental health care services.
Competitor Landscape
Psyomics faces competition from multiple companies within the health technology sector, particularly those focusing on mental health solutions. Key competitors include:
1. Unmind: A workplace mental health platform emphasizing preventative measures and wellbeing improvement through science-backed tools and organizational engagement strategies, partnering with global brands to foster mentally healthy workplaces.
2. ALCEDIAG: Specializes in precision diagnostics for mental health utilizing innovative blood-based solutions with a focus on RNA editing technologies to advance mental health diagnostics.
3. Neurovation Labs: Targets the diagnosis and treatment of mental health disorders, particularly PTSD, with research focusing on biomarkers for precision medicine, offering both diagnostic and therapeutic tools.
4. PsycApps and Woebot Health: These companies provide digital tools and platforms aimed at improving mental health and wellbeing through technology and AI-driven solutions.
Other notable competitors include DAS Health, Blueprint, BehaVR, Aiberry, Genetika+, ALCEDIAG, and CynapseDx, each providing various mental health services and tools.
Technology and Strategy
Psyomics employs platforms like HubSpot and other CRM tools to enhance its operational efficiency and customer engagement. This technological framework facilitates effective service management and customer interaction, crucial in the competitive digital health landscape.
Under CEO Melinda Rees, who enjoys high approval ratings signaling confidence in Psyomics's strategic direction, the company is well-positioned within the digital health market, addressing the increasing need for accessible mental health resources.
For further information or to explore tailored implementations of Psyomics's solutions, potential partners are encouraged to book a demo and learn about bespoke use cases suited to specific healthcare requirements.
